Esther Zamora Adelantado

3PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.

Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora

|Dec 08, 2022
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.

Nikaoly Ciriaco, Esther Zamora, Santiago Escrivá-de-Romaní

|Oct 07, 2021
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.

Sherko Kuemmel, Mario Campone, Delphine Loirat

Pageof 1

Frequent Collaborators

1 joint publications

Nikaoly Ciriaco

1 joint publications

Santiago Escrivá-de-Romaní

1 joint publications

José Jiménez Flores

1 joint publications

Vicente Peg